We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Bill Would Change FDA Review Path for IVDs, LDTs
New Bill Would Change FDA Review Path for IVDs, LDTs
November 5, 2010
A new bill is in the works that would create a separate FDA regulatory pathway for in vitro diagnostics (IVDs) and laboratory-developed tests (LDTs).